---
figid: PMC4782155__fimmu-07-00056-g003
figlink: /pmc/articles/PMC4782155/figure/F3/
number: Figure 3
caption: miR-146a-5p and miR-155-5p mechanism of action under normal conditions and
  early stages of inflammation (, , ). During the early stages of inflammation in
  GVHD, the TLR and Janus Kinase (JAK)-STAT1 pathway are activated by LPS and IFN-γ,
  respectively. Under such conditions, miR-146a-5p and miR-155-5p have reduced expression
  levels. This results in minor alterations of the mRNA target levels and may therefore
  represent subclinical early inflammatory GVHD.
pmcid: PMC4782155
papertitle: miR-146a and miR-155 Expression Levels in Acute Graft-Versus-Host Disease
  Incidence.
reftext: Sadaf Atarod, et al. Front Immunol. 2016;7:56.
pmc_ranked_result_index: '127951'
pathway_score: 0.9359432
filename: fimmu-07-00056-g003.jpg
figtitle: miR-146a-5p and miR-155-5p mechanism of action under normal conditions and
  early stages of inflammation (, , )
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4782155__fimmu-07-00056-g003.html
  '@type': Dataset
  description: miR-146a-5p and miR-155-5p mechanism of action under normal conditions
    and early stages of inflammation (, , ). During the early stages of inflammation
    in GVHD, the TLR and Janus Kinase (JAK)-STAT1 pathway are activated by LPS and
    IFN-γ, respectively. Under such conditions, miR-146a-5p and miR-155-5p have reduced
    expression levels. This results in minor alterations of the mRNA target levels
    and may therefore represent subclinical early inflammatory GVHD.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JAK1
  - NFKB2
  - IRAK1
  - TRAF6
  - REL
  - NFKB1
  - JAK2
  - SP2
  - TLR4
  - RELB
  - IRF6
  - NFKBIA
  - RELA
  - TYK2
  - IFNA1
  - JAK3
genes:
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: IRAK1
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: SPII
  symbol: SP2
  source: hgnc_symbol
  hgnc_symbol: SP2
  entrez: '6668'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: LPS
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: IKBa
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
chemicals: []
diseases: []
---
